Jan Endell,Konstantin Petropoulos,Peter Kelemen,Ranier Boxhammer,Markus Rückert
申请号：
US16342645
公开号：
US20190241656A1
申请日:
2017.10.27
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present disclosure describes a pharmaceutical combination of an anti-CD19 antibody and a BCL-2 inhibitor for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and/or acute lymphoblastic leukemia.
